_________ false

אורמד פארמסוטיקלס אינק	2 379
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	13866

	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	11/08/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-092700	Time of broadcast: 10:09 10:09

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Form 10-Q - Q2 2023

Form_10-Q_-_Q2_2023_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 08/08/2023
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: SILBERMAN DAVID JOSEPH BENJAMIN Position of Signatory in the reporting corporation: CFO & Vice President Finance Name of Employer Company:
Address: Mamilla 20 , Jerusalem 9414904 Telephone: 054-6877398 Facsimile: E-mail: david@oramed.com 1
USA